Ying and Yang of Stat3 in pathogenesis of aortic dissection

Hiroki Aoki1, Ryohei Majima2, Yohei Hashimoto2

  • 1Cardiovascular Research Institute, Kurume University, Kurume, Fukuoka, Japan.

Journal of Cardiology
|November 5, 2020
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) plays a dual role in aortic dissection (AD). Its activation in macrophages promotes AD, while in smooth muscle cells, it protects the aorta by reinforcing tissue strength.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Pathology

Background:

  • Aortic dissection (AD) is a life-threatening condition with poorly understood causes.
  • Interleukin-6 (IL-6) and inflammatory cells, particularly macrophages, are implicated in AD pathogenesis.
  • Signal transducer and activator of transcription 3 (STAT3) is a key mediator of inflammatory responses activated by IL-6.

Purpose of the Study:

  • To investigate the cell type-specific role of STAT3 in the development of aortic dissection.
  • To elucidate how STAT3 activation in macrophages versus smooth muscle cells influences aortic tissue integrity.

Main Methods:

  • Utilized genetically modified mice with tissue-specific deletion of Suppressor of Cytokine Signaling 3 (Socs3) to enhance STAT3 activation in macrophages or smooth muscle cells (SMCs).
  • Analyzed macrophage differentiation (M1/M2), SMC response, fibroblast activation, and collagen deposition in the aortic wall.
  • Assessed the severity of aortic dissection in response to altered STAT3 signaling.

Main Results:

  • Macrophage-specific enhancement of STAT3 signaling led to M1 polarization, suppressed SMC repair, and exacerbated AD.
  • SMC-specific enhancement of STAT3 signaling resulted in chronic activation, M2 polarization, fibroblast activation, increased collagen deposition, and protection against AD.
  • STAT3 activation differentially impacts aortic tissue, promoting destruction in macrophages and reinforcement in SMCs.

Conclusions:

  • STAT3's role in AD is context-dependent, balancing aortic tissue destruction and reinforcement based on cell type and activation kinetics.
  • Understanding these cell-specific STAT3 dynamics is crucial for deciphering AD pathogenesis and developing targeted therapies.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
256
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
103
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
139
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.7K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
159
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
233